TY - JOUR AU - Botha, J. L. AU - Bray, F. AU - Sankila, R. AU - Parkin, D. M. PY - 2003 DA - 2003// TI - Breast cancer incidence and mortality trends in 16 European countries JO - Eur J Cancer VL - 39 UR - https://doi.org/10.1016/S0959-8049(03)00118-7 DO - 10.1016/S0959-8049(03)00118-7 ID - Botha2003 ER - TY - CHAP AU - Harris, J. AU - Morrow, M. AU - Norton, L. PY - 1997 DA - 1997// TI - Malignant tumors of the breast BT - Principles and Practice of Oncology PB - Lippincott-Raven CY - Philadelphia. Pennsylvania ID - Harris1997 ER - TY - JOUR AU - Chlebowski, R. T. AU - Kuller, L. H. AU - Prentice, R. L. AU - Stefanick, M. L. AU - Manson, J. E. AU - Gass, M. AU - Aragaki, A. K. AU - Ockene, J. K. AU - Lane, D. S. AU - Sarto, G. E. AU - Rajkovic, A. AU - Schenken, R. AU - Hendrix, S. L. AU - Ravdin, P. M. AU - Rohan, T. E. AU - Yasmeen, S. AU - Anderson, G. PY - 2009 DA - 2009// TI - Breast cancer after use of estrogen plus progestin in postmenopausal women JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0807684 DO - 10.1056/NEJMoa0807684 ID - Chlebowski2009 ER - TY - CHAP AU - Wood, W. C. AU - Muss, H. B. AU - Solin, L. J. AU - Olopade, O. I. PY - 2005 DA - 2005// TI - Malignant tumors of the breast BT - Principles and Practice of Oncology PB - Lippincott Williams and Wilkins CY - Philadelphia ID - Wood2005 ER - TY - JOUR AU - Di Leo, A. AU - Larsimont, D. AU - Beauduin, M. AU - Cardoso, F. AU - Gancberg, D. AU - Rouas, G. PY - 1999 DA - 1999// TI - CMF or anthracycline based adjuvant chemotherapy for node-positive breast cancer patients JO - Proc Am Soc Clin Oncol VL - 18 ID - Di Leo1999 ER - TY - JOUR AU - Yarden, Y. PY - 2001 DA - 2001// TI - Biology of HER2 and its importance in breast cancer JO - Oncology VL - 61 UR - https://doi.org/10.1159/000055396 DO - 10.1159/000055396 ID - Yarden2001 ER - TY - JOUR AU - Ivkovic-Kapicl, T. AU - Knezevic-Usaj, S. AU - Djilas-Ivanovic, D. AU - Panjkovic, M. PY - 2007 DA - 2007// TI - Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer JO - In Vivo VL - 21 ID - Ivkovic-Kapicl2007 ER - TY - JOUR AU - Osyka, K. AU - Ishioka, C. PY - 2007 DA - 2007// TI - TP53 mutations and molecular epidemiology JO - Gan To Kagaku Ryoho VL - 34 ID - Osyka2007 ER - TY - JOUR AU - Yamashita, H. AU - Nishio, M. AU - Toyama, T. AU - Sugiura, H. AU - Zhang, Z. AU - Iwase, S. PY - 2004 DA - 2004// TI - Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer JO - Breast Cancer Res VL - 6 UR - https://doi.org/10.1186/bcr738 DO - 10.1186/bcr738 ID - Yamashita2004 ER - TY - JOUR AU - Chang, K. AU - Ding, I. AU - Kern, F. G. AU - Willingham, M. C. PY - 1991 DA - 1991// TI - Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumors JO - J Histochem Cytochem VL - 39 UR - https://doi.org/10.1177/39.9.1680897 DO - 10.1177/39.9.1680897 ID - Chang1991 ER - TY - JOUR AU - Gardmark, T. AU - Wester, K. AU - Torre, M. D. AU - Carlsson, J. AU - Malmström, P. U. PY - 2005 DA - 2005// TI - Analysis of Her-2\ neu expression in primary bladder carcinoma and corresponding metastases JO - BJU International VL - 95 UR - https://doi.org/10.1111/j.1464-410X.2005.05452.x DO - 10.1111/j.1464-410X.2005.05452.x ID - Gardmark2005 ER - TY - JOUR AU - Apple, S. K. AU - Hecht, J. R. AU - Lewin, D. W. AU - Jahromi, S. A. AU - Grody, W. W. AU - Nieberg, R. K. PY - 1999 DA - 1999// TI - Immunohistochemical evaluation of K-ras, P53 and HER-2/neu expression in hyperplastic evidence for multistep carcinogenesis., dysplastic, and carcinomatous lesions of the pancreas JO - Human Pathology VL - 30 UR - https://doi.org/10.1016/S0046-8177(99)90265-4 DO - 10.1016/S0046-8177(99)90265-4 ID - Apple1999 ER - TY - JOUR AU - Vrbanec, D. AU - Petricevic, B. PY - 2007 DA - 2007// TI - Estrogen and Progesterone receptor status in primary breast cancer - a study of 11,273 patients from the year 1990 to 2002 JO - Coll Antropol VL - 31 ID - Vrbanec2007 ER - TY - JOUR AU - Rhodes, A. AU - Jasani, B. AU - Balaton, A. AU - Barnes, D. AU - Miller, K. PY - 2000 DA - 2000// TI - Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patients age, assay sensitivity, threshold value and mammographic screening JO - J Clin Patholo VL - 53 UR - https://doi.org/10.1136/jcp.53.9.688 DO - 10.1136/jcp.53.9.688 ID - Rhodes2000 ER - TY - JOUR AU - Caleffi, M. AU - Teague, M. W. AU - Jensen, R. A. AU - Vnencak-Jones, C. L. AU - DuPont, W. D. AU - Parl, F. F. PY - 1994 DA - 1994// TI - P53 gene mutations and Steriod receptor status in breast cancer. Clinico pathologic correlations and prognostic assessment JO - Cancer VL - 73 UR - https://doi.org/3.0.CO;2-5 DO - 3.0.CO;2-5 ID - Caleffi1994 ER - TY - JOUR AU - Van Agthoven, T. AU - Timmermans, M. AU - Foekens, J. A. AU - Doressers, L. C. AU - Henzen-Logmans, S. C. PY - 1994 DA - 1994// TI - Differential expression of estrogen, progesterone and epidermal growth factor receptors in normal, benign and malignant human breast tissues using dual staining immunohistochemistry JO - Am J Pathol VL - 144 ID - Van Agthoven1994 ER - TY - JOUR AU - Briner, W. E. PY - 2006 DA - 2006// TI - The evolution of Depleted Uranium as an environmental risk factor: Lessons from other metals JO - Int J Environ Res Public Health VL - 3 UR - https://doi.org/10.3390/ijerph2006030016 DO - 10.3390/ijerph2006030016 ID - Briner2006 ER - TY - JOUR AU - Miller, A. C. AU - Brooks, K. AU - Smith, J. AU - Page, N. PY - 2004 DA - 2004// TI - Effects of the military-relevant heavy metals, depleted uranium and heavy metals tungsten-alloy on gene expression in human liver carcinoma (HepG2) JO - Mol Cell Biochem VL - 255 UR - https://doi.org/10.1023/B:MCBI.0000007280.72510.96 DO - 10.1023/B:MCBI.0000007280.72510.96 ID - Miller2004 ER - TY - JOUR AU - Yazzie, M. AU - Gamble, S. L. AU - Civitello, E. R. AU - Stearns, D. M. PY - 2003 DA - 2003// TI - Uranyl acetate causes DNA single strand breaks in vitro in the presence of ascorbate (vitamin C) JO - Chem Res Toxicol VL - 16 UR - https://doi.org/10.1021/tx025685q DO - 10.1021/tx025685q ID - Yazzie2003 ER - TY - JOUR AU - Yang, Z. H. AU - Fan, B. X. AU - Lu, Y. AU - Cao, Z. S. AU - Yu, S. AU - Fan, F. Y. AU - Zhu, M. X. PY - 2002 DA - 2002// TI - Malignant transformation of human bronchial epithelial cell (BEAS-ZB) induced by depleted uranium JO - Ai Zheng VL - 21 ID - Yang2002 ER - TY - JOUR AU - Miller, A. C. AU - Brooks, K. AU - Stewart, M. AU - Anderson, B. AU - Shi, L. AU - McClain, D. AU - Page, N. PY - 2003 DA - 2003// TI - Genomic instability in human osteoblast cells after exposure to depleted uranium: delayed lethality and micronuclei formation JO - J Environ Radioact VL - 64 UR - https://doi.org/10.1016/S0265-931X(02)00053-X DO - 10.1016/S0265-931X(02)00053-X ID - Miller2003 ER - TY - JOUR AU - Miller, A. C. AU - Xu, J. AU - Stewart, M. AU - Brooks, K. AU - Hodge, S. AU - Shi, L. AU - Page, N. AU - McClain, D. PY - 2002 DA - 2002// TI - Observation of radiation-specific damage in human cells exposed to depleted uranium: dicentric frequency and neoplastic transformation as endpoints JO - Radiant Prot Dosimetery VL - 99 UR - https://doi.org/10.1093/oxfordjournals.rpd.a006782 DO - 10.1093/oxfordjournals.rpd.a006782 ID - Miller2002 ER - TY - JOUR AU - Miller, A. C. AU - Fuciarelli, A. F. AU - Jackson, W. E. AU - Ejnik, E. J. AU - Emond, C. AU - Strocko, S. AU - Hogan, J. AU - Page, N. AU - Pellmar, T. PY - 1998 DA - 1998// TI - Urinary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets JO - Mutagenesis VL - 13 UR - https://doi.org/10.1093/mutage/13.6.643 DO - 10.1093/mutage/13.6.643 ID - Miller1998 ER - TY - JOUR AU - McCormick, F. PY - 1999 DA - 1999// TI - Signalling networks that cause cancer JO - Trends in Biochemical Sciences VL - 24 UR - https://doi.org/10.1016/S0968-0004(99)01480-2 DO - 10.1016/S0968-0004(99)01480-2 ID - McCormick1999 ER - TY - JOUR AU - Luo, J. AU - Manning, B. D. AU - Cantley, L. C. PY - 2003 DA - 2003// TI - Targeting the PI3K-Akt pathway in human cancer: rationale and promise JO - Cancer Cell VL - 4 UR - https://doi.org/10.1016/S1535-6108(03)00248-4 DO - 10.1016/S1535-6108(03)00248-4 ID - Luo2003 ER - TY - JOUR AU - Vogelstein, B. AU - Lane, D. AU - Levine, A. J. PY - 2000 DA - 2000// TI - Surfing the P53 network JO - Nature VL - 408 UR - https://doi.org/10.1038/35042675 DO - 10.1038/35042675 ID - Vogelstein2000 ER - TY - JOUR AU - Uchino, S. AU - Saito, T. AU - Inomata, M. AU - Osawa, N. AU - Chikuba, K. AU - Etoh, K. AU - Kobayashi, M. PY - 1996 DA - 1996// TI - Prognostic significance of the P53 mutation in esophageal cancer JO - Jpn J Clin Oncol VL - 26 UR - https://doi.org/10.1093/oxfordjournals.jjco.a023234 DO - 10.1093/oxfordjournals.jjco.a023234 ID - Uchino1996 ER - TY - JOUR AU - Elston, C. W. AU - Ellis, I. O. PY - 1991 DA - 1991// TI - Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up JO - Histopathology VL - 19 UR - https://doi.org/10.1111/j.1365-2559.1991.tb00229.x DO - 10.1111/j.1365-2559.1991.tb00229.x ID - Elston1991 ER - TY - JOUR AU - Al-Azzawi, S. N. PY - 2006 DA - 2006// TI - Depleted uranium radioactive contamination In Iraq: An overview JO - Global Research VL - 1 ID - Al-Azzawi2006 ER - TY - JOUR AU - Salih, F. AU - Abdeen, S. PY - 2007 DA - 2007// TI - Pathobiological features of breast tumors in the State of Kuwait: a comprehensive analysis JO - J Carcinog VL - 6 UR - https://doi.org/10.1186/1477-3163-6-12 DO - 10.1186/1477-3163-6-12 ID - Salih2007 ER - TY - JOUR AU - Lee, W. Y. AU - Jin, Y. T. AU - Chang, T. W. AU - Lin, P. W. AU - Su, I. J. PY - 1999 DA - 1999// TI - Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinoma: a correlation with other biological parameters JO - Histopathology VL - 34 UR - https://doi.org/10.1046/j.1365-2559.1999.00578.x DO - 10.1046/j.1365-2559.1999.00578.x ID - Lee1999 ER - TY - JOUR AU - Allred, D. C. AU - Clark, G. M. AU - Molina, R. AU - Tandon, A. K. AU - Schnitt, S. J. AU - Gilchrist, K. W. AU - Osbrne, C. K. AU - Tormey, D. C. AU - McGuire, W. L. PY - 1992 DA - 1992// TI - Over-expression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer JO - Hum Pathol VL - 23 UR - https://doi.org/10.1016/0046-8177(92)90257-4 DO - 10.1016/0046-8177(92)90257-4 ID - Allred1992 ER - TY - JOUR AU - Al-Dujili, E. A. AU - Al-Janabi, A. A. AU - Pierscionek, T. AU - Yasseen, A. A. PY - 2008 DA - 2008// TI - High prevalence of HER-2/neu overexpression in female breast cancer among an Iraqi population exposed to depleted uranium JO - J of carcinogenesis VL - 7 UR - https://doi.org/10.4103/1477-3163.44026 DO - 10.4103/1477-3163.44026 ID - Al-Dujili2008 ER - TY - JOUR AU - Poller, D. N. AU - Hutchings, C. E. AU - Galea, M. AU - Bell, J. A. AU - Nicholson, R. A. AU - Elston, C. W. AU - Elston, C. W. AU - Blamey, E. W. AU - Elis, I. O. PY - 1992 DA - 1992// TI - p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor JO - Br J Cancer VL - 66 UR - https://doi.org/10.1038/bjc.1992.318 DO - 10.1038/bjc.1992.318 ID - Poller1992 ER - TY - JOUR AU - Nakopoulou, L. L. AU - Alexiadou, A. AU - Theodoropoulos, G. E. AU - Lazaris, A. C. AU - Tzonou, A. AU - Keramopoulos, A. PY - 1996 DA - 1996// TI - Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer JO - J Pathol VL - 179 UR - https://doi.org/3.0.CO;2-O DO - 3.0.CO;2-O ID - Nakopoulou1996 ER - TY - JOUR AU - Carr, J. A. AU - Havstad, S. AU - Zarbo, R. J. AU - Divine, G. AU - Mackowiak, P. AU - Velanovich, V. PY - 2000 DA - 2000// TI - The association of HER-2/neu amplification with breast cancer recurrence JO - Arch Surg VL - 135 UR - https://doi.org/10.1001/archsurg.135.12.1469 DO - 10.1001/archsurg.135.12.1469 ID - Carr2000 ER - TY - JOUR AU - Jukkola, A. AU - Bloigu, R. AU - Soini, Y. AU - Savolainen, E. R. AU - Holli, K. AU - Blanco, G. PY - 2001 DA - 2001// TI - c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease JO - Eur J Cancer VL - 37 UR - https://doi.org/10.1016/S0959-8049(00)00395-6 DO - 10.1016/S0959-8049(00)00395-6 ID - Jukkola2001 ER - TY - JOUR AU - Salmon, D. J. AU - Godolphin, W. AU - Jones, L. A. AU - Holt, J. A. AU - Wong, S. G. AU - Keith, D. E. AU - Levin, W. J. AU - Stuart, S. G. AU - Udove, J. AU - Ulrich, A. PY - 1989 DA - 1989// TI - Studies of the HER-2/neu proto-oncogene in human breast cancer and ovarian cancer JO - Science VL - 244 UR - https://doi.org/10.1126/science.2470152 DO - 10.1126/science.2470152 ID - Salmon1989 ER - TY - JOUR AU - Song, H. S. AU - Do, Y. R. AU - Kang, S. H. AU - Yong, K. J. AU - Kim, Y. S. PY - 2006 DA - 2006// TI - Prognostic significant of imunohistochemical expression of p53 gene in operable breast cancer JO - Cancer Res Treat VL - 384 UR - https://doi.org/10.4143/crt.2006.38.4.218 DO - 10.4143/crt.2006.38.4.218 ID - Song2006 ER - TY - JOUR AU - Yamashita, H. AU - Nishio, M. AU - Toyama, T. AU - Sugiura, H. AU - Zhang, Z. AU - Kobayashi, S. AU - Iwase, H. PY - 2004 DA - 2004// TI - Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer JO - Breast Cancer Res VL - 6 UR - https://doi.org/10.1186/bcr738 DO - 10.1186/bcr738 ID - Yamashita2004 ER - TY - JOUR AU - Tsutsui, S. AU - Ohno, S. AU - Murakam, S. AU - Hachitanda, Y. AU - Oda, S. PY - 2001 DA - 2001// TI - Prognostic value of p53 protein expression in breast cancer, an immunohistochemical analysis of frozen sections in 514 Japanese women JO - Breast Cancer VL - 8 UR - https://doi.org/10.1007/BF02967508 DO - 10.1007/BF02967508 ID - Tsutsui2001 ER - TY - JOUR AU - Iwaya, K. AU - Tsuda, H. AU - Hiraide, H. AU - Tamaki, K. AU - Tamakuma, S. AU - Fukutomi, T. AU - Mukai, K. AU - Hirohashi, S. PY - 1991 DA - 1991// TI - Nuclear p53 immunoreactions associated with poor prognosis of breast cancer JO - Jpn J Cancer Res VL - 82 UR - https://doi.org/10.1111/j.1349-7006.1991.tb02710.x DO - 10.1111/j.1349-7006.1991.tb02710.x ID - Iwaya1991 ER - TY - JOUR AU - Isola, J. AU - Visakorpi, T. AU - Holli, K. AU - Kallioniemi, O. P. PY - 1992 DA - 1992// TI - Association of over-expression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients JO - J Natl Cancer Inst VL - 84 UR - https://doi.org/10.1093/jnci/84.14.1109 DO - 10.1093/jnci/84.14.1109 ID - Isola1992 ER - TY - JOUR AU - Lu, X. AU - Gu, Y. AU - Ding, Y. AU - Song, W. AU - Mao, J. AU - Tan, J. AU - Zaho, H. AU - Han, X. AU - Sun, Y. PY - 2008 DA - 2008// TI - Correlation of ER, PgR, HER-2/neu, p53, and VEGF with clinical characteristics and prognosis in Chinese women with invasive breast cancer JO - Breast J VL - 14 UR - https://doi.org/10.1111/j.1524-4741.2008.00583.x DO - 10.1111/j.1524-4741.2008.00583.x ID - Lu2008 ER - TY - JOUR AU - Beenken, S. W. AU - Grizzle, W. E. AU - Growe, D. R. AU - Conner, M. G. AU - Weiss, H. L. AU - Sellers, M. T. AU - Krontiras, H. AU - Urist, M. M. AU - Bland, K. I. PY - 2001 DA - 2001// TI - Molecular Biomarkers for Breast Cancer Prognosis: Coexpression of c-erbB-2 and p53 JO - Ann Surg VL - 233 UR - https://doi.org/10.1097/00000658-200105000-00006 DO - 10.1097/00000658-200105000-00006 ID - Beenken2001 ER - TY - JOUR AU - Menard, S. AU - Casalini, P. AU - Pilotti, S. AU - Cascinelli, N. AU - Rilke, F. AU - Colnaghi, M. I. PY - 1996 DA - 1996// TI - No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomas JO - J Natl Cancer Inst VL - 88 UR - https://doi.org/10.1093/jnci/88.14.1002 DO - 10.1093/jnci/88.14.1002 ID - Menard1996 ER -